Keapstone Therapeutics

0 followers


Keapstone Therapeutics is a single asset biotech developing drugs that target the Nrf2 signalling pathway (KEAP1 inhibitors) for two devastating conditions – Parkinson’s and Motor Neuron Disease (MND) – which together affect more than 130,000 people in the UK. Keapstone was co-founded in February 20... Read more

Employees

1-10

Links

Org chart

This company has no org chart yet

Teams

This company has no teams yet